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Abstract
Background: The minimal physical activity intensity that would confer health benefits among adolescents is unknown. The
purpose of this study was to examine the associations of accelerometer-derived light-intensity (split into low and high)
physical activity, and moderate- to vigorous-intensity physical activity with cardiometabolic biomarkers in a large
population-based sample.
Methods: The study is based on 1,731 adolescents, aged 12–19 years from the 2003/04 and 2005/06 National Health and
Nutrition Examination Survey. Low light-intensity activity (100–799 counts/min), high light-intensity activity (800 counts/min
to ,4 METs) and moderate- to vigorous-intensity activity ($4 METs, Freedson age-specific equation) were accelerometer-
derived. Cardiometabolic biomarkers, including waist circumference, systolic blood pressure, diastolic blood pressure, HDL-
cholesterol, and C-reactive protein were measured. Triglycerides, LDL- cholesterol, insulin, glucose, and homeostatic model
assessments of b-cell function (HOMA-%B) and insulin sensitivity (HOMA-%S) were also measured in a fasting sub-sample
(n = 807).
Results: Adjusted for confounders, each additional hour/day of low light-intensity activity was associated with 0.59 (95% CI:
1.18–0.01) mmHG lower diastolic blood pressure. Each additional hour/day of high light-intensity activity was associated
with 1.67 (2.94–0.39) mmHG lower diastolic blood pressure and 0.04 (0.001–0.07) mmol/L higher HDL-cholesterol. Each
additional hour/day of moderate- to vigorous-intensity activity was associated with 3.54 (5.73–1.35) mmHG lower systolic
blood pressure, 5.49 (1.11–9.77)% lower waist circumference, 25.87 (6.08–49.34)% lower insulin, and 16.18 (4.92–28.53)%
higher HOMA-%S.
Conclusions: Time spent in low light-intensity physical activity and high light-intensity physical activity had some favorable
associations with biomarkers. Consistent with current physical activity recommendations for adolescents, moderate- to
vigorous-intensity activity had favorable associations with many cardiometabolic biomarkers. While increasing MVPA should
still be a public health priority, further studies are needed to identify dose-response relationships for light-intensity activity
thresholds to inform future recommendations and interventions for adolescents.
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Introduction
In order to improve health, the World Health Organization
recommends that adolescents should accumulate at least 60 minutes
of daily physical activity that is of moderate-to vigorous-intensity
(MVPA) [1]. This includes activities such as brisk walking, bicycling,
and soccer [2]. Many countries and organizations have made
similar recommendations [3–5]. However, recent findings using
objective measurement in large population samples show that a high
proportion of adolescents are not participating in sufficient MVPA
on a daily basis [6,7]. For instance, 92% of adolescents assessed by
accelerometer in the US National Health and Nutrition Examina-
tion Survey (NHANES) were classified as not meeting current
physical activity guidelines [6]. Similar statistics were reported for
Canadian adolescents in the Canadian HealthMeasures Survey [7].
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For adolescents, physical activities at the higher end of the
intensity continuum have stronger health benefits, relative to
physical activities of lower intensities [8–12]. However, the
majority of the evidence that has informed current physical
activity guidelines has been generated from studies that have
focused on the health associations with physical activities of at least
moderate intensity [8,13]. Thus, the minimal physical activity
intensity that would confer health benefits among adolescents is
unknown. This is of considerable public health interest because
reducing sedentary pursuits by increasing time spent in light-
intensity activities may be a feasible and potentially beneficial first
step for the large number of adolescents not meeting physical
activity guidelines, especially those participating in no or minimal
physical activity. Furthermore, MVPA only accounts for a small
proportion of waking hours among adolescents [6,7], even if they
are accumulating the recommended 60 minutes throughout the
day [14]. In contrast, there may be substantially more opportu-
nities to increase light-intensity activities in a given day through
incidental activities such as light ambulatory movement [14].
Capturing activity across the intensity spectrum, inclusive of
light-intensity, is one of several advantages of measuring physical
activity objectively with accelerometers, relative to the use of self-
or proxy-report measures [15,16]. Light-intensity activities range
from static (e.g., standing) to dynamic (e.g., slow walking) [2,17].
Of the limited number of studies that have investigated the
relationships of accelerometer-derived light-intensity activity with
health outcomes among adolescents [7,12,18–22], most have not
observed beneficial associations with weight status [7,12,19–21]
nor with other cardiometabolic biomarkers [12,22]. One potential
reason for the null findings is that the full range of light-intensity
activities (i.e., static to dynamic) have been categorized into one
light-intensity variable in previous studies. Given that health
benefits appear to increase with activity intensity, it is possible that
the more dynamic activities on the higher end of the light-intensity
continuum may have stronger associations with cardiometabolic
biomarkers, compared with the more static activities on the lower
end of the light-intensity continuum. Consequently, to further
understand the relationships of lower intensities of activity with
adolescents’ health, it is important to distinguish between the lower
and upper components of the light-intensity activity spectrum.
The purpose of the study was to examine the associations of
accelerometer-derived low light-intensity physical activity (LLPA),
high light-intensity physical activity (HLPA) and MVPA with
cardiometabolic biomarkers in a large population-based sample of
US adolescents.
Methods
Participants
NHANES is a large ongoing national surveillance study
conducted in the United States [23]. NHANES uses a complex
multi-stage probability sampling procedure to select a represen-
tative sample of the US population from all age groups. Data are
collected through home interviews and physical exams, which are
conducted in mobile examination centers [23]. Accelerometer
data are available for the 2003/04 and 2005/06 NHANES cycles.
Out of the 4,591 NHANES participants aged 12–19, a total of
3,779 wore an accelerometer and were eligible for inclusion in this
study.
Ethics Statement
Ethics approval was obtained from the National Centre for
Health Statistics Research Ethics Review Board. Written informed
consent was obtained from all participants and their parents/
guardians if ,18 years old.
Physical Activity
Physical activity variables were derived from the uniaxial
ActiGraph model 7164 accelerometer (ActiGraph, Ft. Walton
Beach, FL). Participants were asked to wear the accelerometer on
their right hip for seven consecutive days except when sleeping or
during water-based activities. Data were collected in one minute
epochs with NHANES survey collaborators excluding unreason-
able or biologically implausible values [23]. Non-wear time was
defined as a period of$60 minutes of continuous zero counts [24].
Only participants with $10 hours of wear time per day for a
minimum of four days, including at least one weekend day, were
included in the analyses [25]. Sedentary time was classified as
,100 counts per minute (cpm) [16,26,27] and MVPA was
classified as $4 metabolic equivalents (METs), according to
Freedson’s age-specific regression equation [28]. Calibration
studies indicate that a 4 MET threshold represents brisk walking
in adolescents, which is a standard marker of moderate-intensity
physical activity [16]. The remaining time was classified as either
LLPA (100–799 counts/min) or HLPA (800 counts/min to ,4
METs). The 800 cpm threshold was chosen because recent studies
have indicated that this published sedentary cut-point captures
both sedentary time and static light-intensity activities such as
standing [26]. The Freedson regression equation was not used to
isolate LLPA because prediction equations have been shown to be
inaccurate for lower intensity activities [17]. To adjust for wear
time, accelerometer-derived variables were standardized by using
the residuals obtained when regressing the variables on wear time
[29].
Cardiometabolic Biomarkers
Waist circumference, systolic and diastolic blood pressure, HDL
cholesterol, and C-reactive protein were examined in the full
sample. Additionally, triglycerides, LDL cholesterol, plasma
glucose, plasma insulin, and homeostatic model assessments of
b–cell function (HOMA-%B) and insulin sensitivity (HOMA-%S)
were examined in a sub-sample of participants who attended the
morning examination and provided fasting blood measures.
Furthermore, 2 hour plasma glucose was examined; however, this
measure was only available in the 2005/2006 fasting sub-sample.
Only participants who reported fasting for $8 hours were
included in the fasting subsample analyses [23]. Detailed
descriptions of these measurements are available through the
NHANES website [23].
Covariates
Age, sex, race (as classified by investigators: non-Hispanic
White, non-Hispanic Black, Mexican American, other), socioeco-
nomic status (SES), smoking (yes or no), total dietary intake,
saturated fat, and sodium intake were considered as covariates.
SES was measured using the poverty-to-income ratio, which is a
ratio between family income and poverty threshold [23]. Smoking
was assessed by asking participants if they had previously tried
cigarette smoking. Total dietary intake, saturated fat and sodium
intake were derived from a 24 hour recall. Saturated fat (#10% or
.10% of total calories) and sodium (#2300 or .2300 mg/day)
were dichotomized based on US dietary guidelines [30].
Statistical Analysis
Analyses were conducted using SAS version 9.2 (SAS Institute
Inc., Cary, NC) and accounted for the complex design and sample
Physical Activity and Cardiometabolic Biomarkers
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weights of NHANES. Since missing data (mostly due to
accelerometer non-compliance) was substantial, and adolescents
included in the full analyses were slightly younger (0.4 years;
P,0.05) compared to adolescents that were excluded due to
missing data, sample weights were re-weighted for non-response to
achieve a representative sample. The assumption of normality in
the regression models for biomarkers was assessed by examining
residuals. Waist circumference, C-reactive protein, triglycerides,
LDL-cholesterol, insulin, HOMA-%B, and HOMA-%S were log-
transformed. Separate multiple linear regression models were used
to examine the association between each physical activity exposure
and cardiometabolic biomarkers. Results are expressed as the
Table 1. Participant Characteristics.
Variables Total Sample (N=4455) Full sample (N=1731) Fasting sub-sample (N=807)
Socio-demographic
Age (years) 14.9 (13.0–16.9) 14.5 (12.8–16.6) 14.7 (12.8–16.8)
Sex (%)
Male 50.9 50.9 50.9
Female 49.1 49.1 49.1
Race (%)
Non-Hispanic White 61.7 63.8 62.8
Non-Hispanic Black 16.1 15.1 15.0
Mexican-American 12.7 11.3 11.3
Other 9.5 9.8 10.9
Poverty to income ratio 2.5 (1.1–4.1) 2.5 (1.2–4.1) 2.5 (1.2–4.2)
Behavioral
Ever tried smoking (%)
Yes – 33.3 35.0
No – 66.7 65.0
Total energy intake (kcal) – 2175.0 (1599.5–2778.5) 2232.2 (1635.5–2873.5)
Sodium Intake (%) –
#2300 mg/day – 24.3 23.2
.2300 mg/day – 75.7 76.8
Saturated Fat (%) –
#10% of total calories – 33.0 37.3
.10% of total calories – 67.0 62.7
Accelerometer-derived variables
Total wear time (min/day) – 862.5 (801.9–928.1) 868.1 (803.0–929.7)
LLPA (min/day){ – 249.9 (210.1–296.2) 244.0 (204.3–296.8)
HLPA (min/day){ – 102.2 (75.0–130.1) 98.9 (71.1–127.8)
MVPA (min/day){ – 18.9 (9.4–37.2) 18.0 (9.0–35.8)
Biomarkers
Waist Circumference (cm) – 76.9 (70.9–86.1) –
Systolic Blood Pressure (mmHg) – 108.8 (101.6–114.8) –
Diastolic Blood Pressure (mmHg) – 59.9 (53.0–66.9) –
HDL Cholesterol (mmol/L) – 1.3 (1.1–1.5) –
C-reactive Protein (mg/dL) – 0.04 (0.01–0.11) –
Trigycerides (mmol/L) – – 0.8 (0.6–1.1)
LDL Cholesterol (mmol/L) – – 2.3 (1.8–2.7)
Plasma Glucose (mmol/L) – – 5.0 (4.8–5.3)
Insulin (pmol/L) – – 53.2 (34.2–76.5)
HOMA-%B (N= 768) – – 96.5 (74.6–128.6)
HOMA-%S (N= 768) – – 94.8 (68.0–138.7)
LLPA= low light-intensity physical activity; HLPA= high light-intensity physical activity; MVPA=moderate- to vigorous-intensity physical activity; HDL =High-density
lipoprotein cholesterol; LDL = Low-density lipoprotein cholesterol; HOMA-%B=homeostatic model assessments of b–cell function; and HOMA-%S homeostatic model
assessments of insulin sensitivity. Data presented as median (inter-quartile range) for continuous variables and % for categorical variables.
{Corrected for wear time using the residuals method, with cutpoints (in order) of 100 to 799 counts per minute (cpm), 800 cpm to 4METs (Freedson age-specific
equation) and $4+ METs.
doi:10.1371/journal.pone.0071417.t001
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effect on the mean levels of each biomarker (or relative rates, for
log-transformed outcomes) for each additional hour/day of
physical activity. Model 1 adjusted for potential confounders
identified from the literature (age, sex, ethnicity, SES, smoking,
total energy intake, sodium, and saturated fat) [12,22,31]. Model 2
adjusted additionally for waist circumference, which may be a
confounder but also may be a mediator.
Additional analyses further adjusted for MVPA in the LLPA
and HLPA final models to determine if associations with
cardiometabolic biomarkers were independent of MVPA. Seden-
tary behavior was not included in the models because it was highly
correlated with both LLPA and HLPA (r.0.80). Further, a
sensitivity analysis was conducted to determine whether any
associations of HLPA and MVPA with cardiometabolic biomark-
ers were consistent when MVPA was defined as $3 METs. While
there is established precedence in the pediatric literature to define
MVPA as$4 METs [16,32],$3 METs has been used in previous
studies [16]. Finally, moderation analyses were conducted to
examine whether associations differed by age, sex, race, and waist
circumference. Statistical significance was set at P,0.05 for main
effects and P,0.001 for interactions. Given our main research
question, a strict criterion was used for interactions to minimize
type 1 error.
Results
Of the 3,779 eligible participants, 1,633 were excluded due to
incomplete accelerometer data and an additional 415 were
excluded due to incomplete information on outcome or covariate
measures. In total, 1,731 were included in the full analyses, 807 in
the fasting analyses, and 359 for the 2 hour plasma glucose
analyses. With reweighting to correct for non-response, the full
sample and fasting subsample both closely resembled the US
adolescent population (Table 1). Weighted to the population,
median age was 15 years, approximately half of the sample was
male, 64% were non-Hispanic White, 15% were non-Hispanic
Black, and 11% Mexican-American. The median time spent in
each physical activity category diminished with intensity: 250, 102
and 19 minutes/day in LLPA, HLPA and MVPA, respectively.
Associations of physical activity with cardiometabolic biomark-
ers in the full sample are shown in Table 2. There were beneficial
associations of LLPA with diastolic blood pressure in the fully
adjusted model (model 2). Each additional hour/day of LLPA was
associated with 0.59 (95% CI: 1.18–0.01) mmHG lower diastolic
blood pressure. There were also beneficial associations of HLPA
with diastolic blood pressure and HDL-cholesterol. More specif-
ically, in the fully adjusted model, each additional hour/day of
HLPA was associated with 1.67 (95% CI: 2.94–0.39) mmHG
lower diastolic blood pressure and 0.04 (0.001–0.07) mmol/L
higher HDL-cholesterol. For MVPA, there were beneficial
associations with waist circumference and systolic blood pressure
in the fully adjusted models. Each additional hour/day of MVPA
was associated with 3.54 (5.73–1.35) mmHG lower systolic blood
pressure. After back-transforming waist circumference from the
log scale, an additional hour/day of MVPA was associated with
5.49 (1.11–9.77) % lower waist circumference (equivalent at the
mean to approximately 4 cm).
Associations of physical activity with cardiometabolic biomark-
ers in the fasting sub-sample are shown in Table 3. No associations
were observed between LLPA or HLPA with any assessed
biomarkers. However, there were beneficial associations of MVPA
with insulin, and HOMA-%S. In the fully adjusted model, after
back-transforming insulin and HOMA-%S from the log scale,
each additional hour/day of MVPA was associated with 25.87
(6.08–49.34) % lower insulin (equivalent at the mean to
approximately 17 mmol/L), and a 16.18 (4.92–28.53) % higher
HOMA-%S.
Table 2. Associations of time spent in LLPA, HLPA, and MVPA with cardiometabolic biomarkers in the full sample (n = 1731).
LLPA (hour/day) HLPA (hour/day) MVPA(hour/day)
b (95% CI) b (95% CI) b (95% CI)
Waist Circumference (cm){
Model 1 20.001 (20.012, 0.009) 0.008 (20.008, 0.024) 20.052 (20.093, 20.011)*
Systolic blood pressure (mmHG)
Model 1 0.373 (20.636, 1.382) 20.448 (21.383, 0.489) 24.531 (27.113, 21.950)*
Model 2 0.401 (20.649, 1.451) 20.607 (21.606, 0.392) 23.541 (25.732, 21.350)*
Diastolic Blood Pressure (mmHG)
Model 1 20.596 (21.188, 20.005)* 21.640 (22.959, 20.321)* 21.820 (24.353, 0.714)
Model 2 20.592 (21.176, 20.007)* 21.667 (22.942, 20.385)* 21.677 (24.189, 0.835)
HDL-cholesterol (mmol/L)
Model 1 0.009 (20.013, 0.030) 0.031 (20.008, 0.071) 0.085 (0.024, 0.195)
Model 2 0.008 (20.013, 0.028) 0.037 (0.001, 0.073)* 0.050 (20.049, 0.149)
C-reactive protein (md/dL) {
Model 1 20.012 (20.089, 0.064) 0.081 (20.061, 0.224) 20.019 (20.377, 0.339)
Model 2 20.007 (20.070, 0.056) 0.052 (20.078, 0.181) 0.176 (20.125, 0.477)
LLPA= low light-intensity physical activity; HLPA= high light-intensity physical activity; MVPA=moderate- to vigorous-intensity physical activity; and HDL =High-density
lipoprotein cholesterol.
*P,0.05;
{Log transformed; b (95% CI) = unstandardized regression coefficients and 95% confidence intervals.
Model 1 is adjusted for age, sex, ethnicity, SES, smoking, total energy intake, sodium, and saturated fat; Model 2 is adjusted for confounders in model 2 and waist
circumference.
doi:10.1371/journal.pone.0071417.t002
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The associations of LLPA with diastolic blood pressure (b=–
0.54 [95% CI: –1.09, 0.02]; P=0.06) and HLPA with HDL-
cholesterol (0.03 [–0.001, 0.07]; P=0.06) became borderline non-
significant after further adjusting for MVPA. Conversely, the
beneficial associations of HLPA with diastolic blood pressure
(21.65 [22.98, 20.33]) remained. In addition, associations of
HLPA with diastolic blood pressure and HDL-cholesterol
remained when MVPA was defined as $3 METs (See Table
S1). With the exception of insulin and HOMA-%S, statistical
conclusions regarding associations of MVPA with biomarkers were
identical using the $3 and $4 MET thresholds (See Tables S1
and S2). No interactions by age, sex, race, or waist circumference
were observed.
Discussion
To better understand the relationship of lower intensities of
physical activity with health, this study examined associations of
accelerometer-derived LLPA and HLPA as well as MVPA with
cardiometabolic biomarkers in a large, population-based sample of
US adolescents. LLPA and HLPA had beneficial associations with
diastolic blood pressure. HLPA also had beneficial associations
with HDL-cholesterol. MVPA had beneficial associations with
many of the biomarkers, including those related to adiposity (waist
circumference), lipid metabolism (HDL-cholesterol), glucose me-
tabolism (insulin and HOMA-%S) and circulation (systolic blood
pressure), but not inflammation (C-Reactive Protein).
A recent systematic review examining the health benefits of
physical activity among children and adolescents was unable to
draw conclusions on the impact of light-intensity physical activity
on health [8]. This was due to the predominant focus on physical
activity of at least moderate-intensity in the eligible observational
and experimental studies reviewed [8]. Studies to date that have
examined the relationship between accelerometer-derived light-
intensity physical activity with health outcomes among adolescents
[7,12,18–22], have not observed favourable associations [7,12,19–
21]. For example, while vigorous-intensity physical activity,
MVPA, and total physical activity (including movement at all
intensities) was associated with markers of total body fat among
365 Spanish adolescents, light-intensity physical activity was not
[20]. Similarly, favourable associations were not observed for light-
intensity physical activity with body mass index, waist circumfer-
ence, systolic blood pressure or cardio-respiratory fitness among
605 Canadian youth aged 9 to 17 years [12].
The contrasting findings between previous research and the
current study may relate to differences in the thresholds used to
define light-intensity physical activity and the tendency to group
Table 3. Associations of time spent in LLPA, HLPA. and MVPA with cardiometabolic biomarkers in the fasting sub-sample (n = 807).
LLPA (hour/day) HLPA (hour/day) MVPA (hour/day)
b (95% CI) B (95% CI) B (95% CI)
Triglycerides (mmo1/L){
Model 1 0.004 (20.012, 0.019) 0.009 (20.010, 0.028) 0.018 (20.058, 0.094)
Model 2 0.003 (20.012, 0.019) 0.009 (20.010, 0.029) 0.021 (20.056, 0.098)
LDL2cholesterol (mmol/L){
Model 1 20.007 (20.032, 0.019) 0.005 (20.010, 0.037) 0.017 (20.111, 0.144)
Model 2 20.007 (20.031, 0.017) 0.005 (20.024, 0.034) 0.025 (20.202, 0.152)
Plasma Glucose (mmol/L)
Model 1 0.004 (20.005, 0.013) 0.013 (20.001, 0.027) 20.015 (20.046, 0.016)
Model 2 0.004 (20.005, 0.013) 0.013 (20.001, 0.027) 20.013 (20.043, 0.017)
Insulin (pmol/L){
Model 1 20.016 (20.078, 0.046) 20.024 (20.127, 0.080) 20.300 (20.545, 20.051)*
Model 2 20.018 (20.060, 0.025) 20.024 (20.108, 0.061) 20.230 (20.401, 20.059)*
HOMA2%B (n = 768){
Model 1 0.001 (20.044, 0.045) 20.022 (20.001, 0.048) 20.111 (20.256, 0.034)
Model 2 20.002 (20.033, 0.030) 20.022 (20.074, 0.031) 20.077 (20.179, 0.020)
HOMA2%S (n = 768){
Model 1 20.013 (20.075, 0.047) 20.013 (20.110, 0.084) 0.203 (0.007, 0.401)*
Model 2 20.010 (20.050, 0.029) 20.013 (20.09, 0.060) 0.150 (0.048, 0.251)*
OGTT sub2sample (n =359)
2h plasma glucose, mmol/l
Model 1 20.092 (20.346, 0.163) 20.109 (20.452, 0.234) 20.511 (21.281, 0.258)
Model 2 20.111 (20.334, 0.113) 20.114 (20.417, 0.188) 20.450 (21.111, 0.212)
LLPA= low light-intensity physical activity; HLPA= high light-intensity physical activity; MVPA=moderate- to vigorous-intensity physical activity; LDL = Low-density
lipoprotein cholesterol; HOMA-%B=homeostatic model assessments of b–cell function; HOMA-%S homeostatic model assessments of insulin sensitivity; and
OGTT =Oral glucose tolerance test.
*P,0.05;
{Log-transformed; b (95% CI) = unstandardized beta coefficients and 95% confidence.
Model 1 is adjusted for age, sex, ethnicity, smoking, total energy intake, sodium, and saturated fat; Model 2 is adjusted for confounders in model 2 and waist
circumference.
doi:10.1371/journal.pone.0071417.t003
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all light-intensity activities from static (i.e., standing) to dynamic
(i.e., slow walking) into a single light-intensity activity variable
[7,12,18–22]. In the present study, when light-intensity was split to
represent static (LLPA) and dynamic (HLPA) activities, LLPA and
HLPA had some benefit with selected biomarkers; however, after
adjusting for MVPA only HLPA had beneficial associations with
diastolic blood pressure. Consistent with previous research in
adolescents [8,31], we observed many beneficial associations
between MVPA and cardiometabolic biomarkers. Furthermore,
the associations for MVPA were stronger when the threshold was
placed at 4 versus 3 METs. Collectively, this further supports the
evidence that the cardiometabolic health benefits of physical
activity tend to increase with the intensity of activity [8–12].
While cardiometabolic health benefits tend to increase with the
intensity of activity, the volume of physical activity diminishes with
increasing intensity. More specifically, the medians in the present
study were 250, 102 and 19 min/day respectively for LLPA,
HLPA, and MVPA. The 19 min/day median is well below the
60 min/day of MVPA that is recommended for health benefits in
the current adolescent physical activity guidelines [1]. Therefore,
the findings from this study have potentially important public
health implications. While participating in 60 minutes or more of
MVPA per day remains the most desirable goal, this may not be
realistic for some adolescents. Being more common than MVPA,
light activities may be more readily attainable and easier to
promote than MVPA, especially in adolescents who are not
meeting physical activity recommendations. Furthermore, increas-
ing time in LLPA (e.g., standing) and HLPA (e.g., light ambulatory
activities) may be an important first step for increasing MVPA
participation in inactive adolescents.
This is the first study to differentiate between the lower and
higher ends of the light-intensity activity spectrum when examin-
ing associations with biomarkers among adolescents. Further
research, including more dose-response studies as well as
experimental studies, is needed to confirm and build upon these
findings. Such evidence could underpin recommendations regard-
ing light-intensity activity in future physical activity guidelines and
inform interventions targeting light-intensity activity, particularly
among adolescents for whom MVPA may present challenges.
Strengths of this study include the large sample of adolescents,
the objective measurement of physical activity variables, and the
examination of several cardiometabolic biomarkers. A major
limitation is the cross-sectional design, precluding causal inferenc-
es. In addition, while we adjusted for several confounders, residual
confounding may have occurred due to unmeasured variables
(e.g., pubertal status was not included in the NHANES dataset) or
measurement error (e.g., smoking status, dietary recall). Further, a
large proportion of participants were excluded due to incomplete
data; however, the re-weighting of the data for non-response
appears to have minimised any selection bias. Finally, while
accelerometers have many advantages over other measures of
physical activity, they nevertheless have limitations. For instance,
accelerometers do not capture all activities, such as swimming,
cycling or load-bearing activities. Additionally, accelerometers
require several decisions regarding data reduction procedures (e.g.,
non-wear time threshold, cut-points) and there is currently a lack
of consensus in the literature on the most optimal procedures to
use [33]. Furthermore, cut-points, although useful for summariz-
ing the data, underutilise the wealth of information that is
captured by accelerometers. New analytic techniques that can
identify patterns of behaviour may further extend our under-
standing of the benefits of physical activity across the intensity
spectrum [34].
Conclusion
Beneficial associations were observed for LLPA and HLPA, in
particular with diastolic blood pressure and HDL-cholesterol.
Consistent with current physical activity recommendations,
MVPA had many favorable associations with cardiometabolic
biomarkers among adolescents. The findings from this study
suggest light-intensity activities may provide a beneficial adjunct to
the current 60 min/day of MVPA recommendation.
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